2nd Annual Lysosomal Disease Summit

The Lysosomal Disease Summit will bring together metabolic and lysosomal disease healthcare practitioners and researchers from Australia and the surrounding Asia-Pacific region, to address the current challenges facing lysosomal disease clinicians and researchers, discuss the latest research updates, and identify opportunities for improvements in the diagnosis and treatment of lysosomal diseases.

The 2024 Lysosomal Disease Summit is intended to build awareness of the incidence and prevalence of lysosomal disorders, strategize improvements to patient identification and specialist referrals, generate discussion around how to increase metabolic and lysosomal disease workforce resources, and identify steps to overcome barriers to diagnosis and treatment.

In addition, the Summit will provide a forum for researchers and clinicians to share their latest findings and to discuss the challenges and opportunities in the field of lysosomal disease research and management. The Summit will feature targeted educational sessions and panel discussions, as well as a collaboration reception.

The program will be intended for all healthcare practitioners, scientists and researchers, patient advocates, and other interested healthcare professionals.